Greenphire Launches ConneX Patient Direct in Response to COVID-19

Published on: 

Applied Clinical Trials

Greenphire has announced the launch of its ConneX Patient Direct service to enable global clinical trial sites to continue their critical work and patient support in an effort to offset the impact of COVID-19. The new service provides "clean transport" for medications, equipment, and healthcare professionals to visit patients in their homes.

For more information, click here.